Join our Provider Community

We’re building a community of mission-driven care providers devoted to creating the future of women’s health research and education.
Blood cells under a microscope
A doctor puts on her mask
Two hands reach out for each other
Two hands reach out for each other

"As an OBGYN, I've seen how common and debilitating vaginal infections can be for women around the world.

As a leading researcher of the vaginal microbiome, my colleagues and I have started to uncover its role in areas beyond vaginal health — including public health challenges like STIs and HIV acquisition, infertility, preterm birth, and more.

I truly believe that Evvy's unique platform combined with the development of new therapeutics will catalyze a new era in women's health."

Dr. Craig Cohen
Professor of Ob/GYN & Reproductive Sciences at UCSF & advisor to Evvy

Vaginal infections are some of the most common infections in people, period.

~30%

of women are diagnosed with bacterial vaginosis (BV) every year, and 80% of cases recur within 3 months of “effective treatment.”

#1

most common bacterial infection in women is a UTI.

327M

women are affected by recurrent yeast infections over their lifetime.

We’re building a longitudinal dataset on the vaginal microbiome that researchers and providers can use to unlock better treatments and care.

Every Evvy test includes:

Clinical grade quality

All Evvy tests are analyzed in a U.S. laboratory that is certified by CLIA standards to ensure accuracy and validity of results.

Patient-focused testing

Evvy’s self-pay price makes frequent testing more accessible and affordable — providing key insights into what interventions are most likely to work based on the current state of the vaginal microbiome.

Actionable results

Our reports integrate relevant research, guidelines and patient data to help you best support your patients.

Evvy is built in collaboration with top OB/GYNs and researchers from UCSF, Cleveland Clinic, Stanford, Harvard, and more.

Dr. Craig Cohen

Dr. Craig Cohen

Advisor
Professor, Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco; Co-Director, University of California Global Health Institute

Dr. Craig Cohen

Advisor
Professor, Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco; Co-Director, University of California Global Health Institute
More

Dr. Cohen is an OB-Gyn research-scientist with over 28 years of studying the vaginal microbiome and its impact on reproductive health.

He led the first investigation to demonstrate an association between women with bacterial vaginosis and HIV, and since has been studying the vaginal microbiome in part to develop live biotherapeutic products to optimize the vaginal microbiome and improve reproductive health outcomes including the prevention of HIV acquisition.

The combined force led by Evvy to develop powerful datasets on the vaginal microbiome combined with the promise of new therapeutics creates the opportunity to significantly improve reproductive health outcomes for women in the US and around the world.

Dr. Oluwatosin Goje

Dr. Oluwatosin Goje

Advisor
OB/GYN and Reproductive Infectious Disease Specialist, Cleveland Clinic

Dr. Oluwatosin Goje

Advisor
OB/GYN and Reproductive Infectious Disease Specialist, Cleveland Clinic
More

Dr. Goje is a Reproductive Infectious Disease Specialist and a Vulvar and Vaginal Health Specialist. She directs a vulvar and vaginal health clinic that serves as a referral center in Midwest United States. Clinically, she manages all complex vulvar and vaginal health disorders from infectious to non-infectious disorders.

Her research is focused on recurrent infectious, vulvovaginitis, and the complex interplay of vaginal health and microbiota.

Her  research pilot program focuses on looking at the microbiome of women with recurrent bacterial vaginosis (BV) after treatment with metronidazole gave her insight ( and corroborated her patients complaints) into the critical role of the microbiome if we are to have a sustained clinical cure in patients with recurrent BV.

Dr. Ava Manieri

Dr. Ava Manieri

Advisor
Head of Research @ Tia, Harvard geneticist with deep expertise in female reproductive health

Dr. Ava Manieri

Advisor
Head of Research @ Tia, Harvard geneticist with deep expertise in female reproductive health
More

Currently, Dr. Manieri is Head of Research at Tia, a next-gen women’s health platform that uses digital wellness apps, brick and mortar clinics, and telehealth services to treat women’s health holistically.

Propelled by purpose, she leads research at Tia in order to bring forth the relevant clinical and scientific literature required to deliver integrated and comprehensive medical care to women. Previously, she completed her PhD under Dr. David Haig at Harvard University.

Professor Londa Schiebinger

Professor Londa Schiebinger

Advisor
Hinds Professor of History of Science at Stanford University & Director, Gendered Innovations in Science, Health & Medicine, Engineering, & Environment

Professor Londa Schiebinger

Advisor
Hinds Professor of History of Science at Stanford University & Director, Gendered Innovations in Science, Health & Medicine, Engineering, & Environment
More

Schiebinger is a leading international expert on gender in science & technology and has addressed the United Nations, the European Parliament, the Korean National Assembly, and numerous funding agencies on that topic.

Schiebinger received her Ph.D. from Harvard University, is an elected member of the American Academy of Arts and Sciences, and the recipient of numerous prizes and awards, including the prestigious Alexander von Humboldt Research Prize and Guggenheim Fellowship.

Gendered Innovations harnesses the creative power of sex, gender, and intersectional analysis to enhance excellence and reproducibility in science and technology: Sex and Gender Analysis Improves Science and Engineering Nature (2019).

Dr. Diana Currie

Dr. Diana Currie

Advisor
Faculty OB/GYN at St. Peter Fam Med Residency; Medical Director of Quality & Care Transformation; WA Medical Commissioner

Dr. Diana Currie

Advisor
Faculty OB/GYN at St. Peter Fam Med Residency; Medical Director of Quality & Care Transformation; WA Medical Commissioner
More

Dr. Diana Currie is a faculty member of the Providence St. Peter Family Medicine Residency department in Olympia, WA, an affiliate of the University of Washington medical school. A passionate educator, she has been teaching medical students and residents for over 25 years. Dr. Currie attended Harvard Medical School where she received an Albert Schweitzer Fellowship in pediatric and adolescent gynecology with a focus on maternal and reproductive health disparities.

A board-certified Ob/Gyn, she values the trust her patients place in her hands, heart and judgement—whether it is to deliver their newborn baby, as they go to sleep on the operating room table, or in the clinic to keep them healthy. She provides women with information about their body which allows them to make informed decisions that can positively impact all areas of their life.

She is also well versed in Functional Medicine and believes that every individual deserves a personalized, whole person approach in achieving their optimum health.

Dr. Catherine L. Haggerty

Dr. Catherine L. Haggerty

Advisor
Associate Professor, Department of Epidemiology & Director, Reproductive, Perinatal & Pediatric Area of Emphasis, University of Pittsburgh

Dr. Catherine L. Haggerty

Advisor
Associate Professor, Department of Epidemiology & Director, Reproductive, Perinatal & Pediatric Area of Emphasis, University of Pittsburgh
More

Dr. Haggerty is a reproductive, perinatal and pediatric epidemiologist with cross-cutting expertise in infectious disease epidemiology and global health.

She has been actively involved in multi-disciplinary research for nearly two decades, leading numerous NIH and CDC funded studies that combine reproductive, infectious disease and molecular epidemiology.

Several of her ongoing projects are focused on the role of the vaginal microbiome in pelvic inflammatory disease, infertility and adverse pregnancy outcomes.

Dr. Okeoma Mmeje

Dr. Okeoma Mmeje

Advisor
Assistant Professor, Obstetrics and Gynecology at Michigan Medicine

Dr. Okeoma Mmeje

Advisor
Assistant Professor, Obstetrics and Gynecology at Michigan Medicine
More

Dr. Mmeje, MPH is an Assistant Professor in the Department Obstetrics and Gynecology at Michigan Medicine.

She attended the University of Michigan Medical School and School of Public Health. In 2013, she was recruited as a member of the Presidential Admission Scholar program focused on Global HIV/AIDS by the department of Obstetrics and Gynecology.

As a fellowship-trained physician researcher, she has expertise in reproductive infectious diseases.

In clinical practice, Dr. Mmeje manages general obstetrics and gynecology conditions in addition to recurrent or persistent cases of vaginitis.

Dr. Momo Vuyisich

Dr. Momo Vuyisich

Advisor
Co-founder and Chief Science Officer at Viome

Dr. Momo Vuyisich

Advisor
Co-founder and Chief Science Officer at Viome
More

Momo is an entrepreneur-scientist who is obsessed with building a healthier future in which chronic diseases and cancers are covered in history books, not TV commercials.

He has used his extensive scientific expertise and business acumen to lead the development of the core Viome technologies, and their application towards healthier humanity. These technologies are enabling the transformation of the current healthcare, which focuses on symptoms management, into a completely novel preventative and curative model, where individuals can take control of their own health.

Momo obtained his PhD in Chemistry from the University of Utah, and BS in Microbiology from the University of Texas at El Paso. He is also an adjunct professor at the New Mexico Tech University.

Dr. Craig Cohen

Dr. Craig Cohen

Advisor
Professor, Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco; Co-Director, University of California Global Health Institute

Dr. Craig Cohen

Advisor
Professor, Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco; Co-Director, University of California Global Health Institute
More

Dr. Cohen is an OB-Gyn research-scientist with over 28 years of studying the vaginal microbiome and its impact on reproductive health.

He led the first investigation to demonstrate an association between women with bacterial vaginosis and HIV, and since has been studying the vaginal microbiome in part to develop live biotherapeutic products to optimize the vaginal microbiome and improve reproductive health outcomes including the prevention of HIV acquisition.

The combined force led by Evvy to develop powerful datasets on the vaginal microbiome combined with the promise of new therapeutics creates the opportunity to significantly improve reproductive health outcomes for women in the US and around the world.

Dr. Diana Currie

Dr. Diana Currie

Advisor
Faculty OB/GYN at St. Peter Fam Med Residency; Medical Director of Quality & Care Transformation; WA Medical Commissioner

Dr. Diana Currie

Advisor
Faculty OB/GYN at St. Peter Fam Med Residency; Medical Director of Quality & Care Transformation; WA Medical Commissioner
More

Dr. Diana Currie is a faculty member of the Providence St. Peter Family Medicine Residency department in Olympia, WA, an affiliate of the University of Washington medical school. A passionate educator, she has been teaching medical students and residents for over 25 years. Dr. Currie attended Harvard Medical School where she received an Albert Schweitzer Fellowship in pediatric and adolescent gynecology with a focus on maternal and reproductive health disparities.

A board-certified Ob/Gyn, she values the trust her patients place in her hands, heart and judgement—whether it is to deliver their newborn baby, as they go to sleep on the operating room table, or in the clinic to keep them healthy. She provides women with information about their body which allows them to make informed decisions that can positively impact all areas of their life.

She is also well versed in Functional Medicine and believes that every individual deserves a personalized, whole person approach in achieving their optimum health.

Dr. Oluwatosin Goje

Dr. Oluwatosin Goje

Advisor
OB/GYN and Reproductive Infectious Disease Specialist, Cleveland Clinic

Dr. Oluwatosin Goje

Advisor
OB/GYN and Reproductive Infectious Disease Specialist, Cleveland Clinic
More

Dr. Goje is a Reproductive Infectious Disease Specialist and a Vulvar and Vaginal Health Specialist. She directs a vulvar and vaginal health clinic that serves as a referral center in Midwest United States. Clinically, she manages all complex vulvar and vaginal health disorders from infectious to non-infectious disorders.

Her research is focused on recurrent infectious, vulvovaginitis, and the complex interplay of vaginal health and microbiota.

Her  research pilot program focuses on looking at the microbiome of women with recurrent bacterial vaginosis (BV) after treatment with metronidazole gave her insight ( and corroborated her patients complaints) into the critical role of the microbiome if we are to have a sustained clinical cure in patients with recurrent BV.

Dr. Catherine L. Haggerty

Dr. Catherine L. Haggerty

Advisor
Associate Professor, Department of Epidemiology & Director, Reproductive, Perinatal & Pediatric Area of Emphasis, University of Pittsburgh

Dr. Catherine L. Haggerty

Advisor
Associate Professor, Department of Epidemiology & Director, Reproductive, Perinatal & Pediatric Area of Emphasis, University of Pittsburgh
More

Dr. Haggerty is a reproductive, perinatal and pediatric epidemiologist with cross-cutting expertise in infectious disease epidemiology and global health.

She has been actively involved in multi-disciplinary research for nearly two decades, leading numerous NIH and CDC funded studies that combine reproductive, infectious disease and molecular epidemiology.

Several of her ongoing projects are focused on the role of the vaginal microbiome in pelvic inflammatory disease, infertility and adverse pregnancy outcomes.

Dr. Ava Manieri

Dr. Ava Manieri

Advisor
Head of Research @ Tia, Harvard geneticist with deep expertise in female reproductive health

Dr. Ava Manieri

Advisor
Head of Research @ Tia, Harvard geneticist with deep expertise in female reproductive health
More

Currently, Dr. Manieri is Head of Research at Tia, a next-gen women’s health platform that uses digital wellness apps, brick and mortar clinics, and telehealth services to treat women’s health holistically.

Propelled by purpose, she leads research at Tia in order to bring forth the relevant clinical and scientific literature required to deliver integrated and comprehensive medical care to women. Previously, she completed her PhD under Dr. David Haig at Harvard University.

Dr. Okeoma Mmeje

Dr. Okeoma Mmeje

Advisor
Assistant Professor, Obstetrics and Gynecology at Michigan Medicine

Dr. Okeoma Mmeje

Advisor
Assistant Professor, Obstetrics and Gynecology at Michigan Medicine
More

Dr. Mmeje, MPH is an Assistant Professor in the Department Obstetrics and Gynecology at Michigan Medicine.

She attended the University of Michigan Medical School and School of Public Health. In 2013, she was recruited as a member of the Presidential Admission Scholar program focused on Global HIV/AIDS by the department of Obstetrics and Gynecology.

As a fellowship-trained physician researcher, she has expertise in reproductive infectious diseases.

In clinical practice, Dr. Mmeje manages general obstetrics and gynecology conditions in addition to recurrent or persistent cases of vaginitis.

Professor Londa Schiebinger

Professor Londa Schiebinger

Advisor
Hinds Professor of History of Science at Stanford University & Director, Gendered Innovations in Science, Health & Medicine, Engineering, & Environment

Professor Londa Schiebinger

Advisor
Hinds Professor of History of Science at Stanford University & Director, Gendered Innovations in Science, Health & Medicine, Engineering, & Environment
More

Schiebinger is a leading international expert on gender in science & technology and has addressed the United Nations, the European Parliament, the Korean National Assembly, and numerous funding agencies on that topic.

Schiebinger received her Ph.D. from Harvard University, is an elected member of the American Academy of Arts and Sciences, and the recipient of numerous prizes and awards, including the prestigious Alexander von Humboldt Research Prize and Guggenheim Fellowship.

Gendered Innovations harnesses the creative power of sex, gender, and intersectional analysis to enhance excellence and reproducibility in science and technology: Sex and Gender Analysis Improves Science and Engineering Nature (2019).

Dr. Momo Vuyisich

Dr. Momo Vuyisich

Advisor
Co-founder and Chief Science Officer at Viome

Dr. Momo Vuyisich

Advisor
Co-founder and Chief Science Officer at Viome
More

Momo is an entrepreneur-scientist who is obsessed with building a healthier future in which chronic diseases and cancers are covered in history books, not TV commercials.

He has used his extensive scientific expertise and business acumen to lead the development of the core Viome technologies, and their application towards healthier humanity. These technologies are enabling the transformation of the current healthcare, which focuses on symptoms management, into a completely novel preventative and curative model, where individuals can take control of their own health.

Momo obtained his PhD in Chemistry from the University of Utah, and BS in Microbiology from the University of Texas at El Paso. He is also an adjunct professor at the New Mexico Tech University.

Two women look at the camera, determinedTwo women look at the camera, determined

The female body shouldn’t be a medical mystery.

By partnering with Evvy, healthcare providers can offer their patients access to vaginal health information that can drive personalized care and lead to improved health outcomes.

Two people hold hands and run down a hallway, grinningA micrograph of bacteriaKnow what's up down there.Did you know? Women weren't required to be in clinical research until 1993